Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study assessing a single dose of tafenoquine co-administered with either artemether+lumefantrine or dihydroartemisinin+piperaquine tet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• Artemether-lumefantrine (artemether and lumefantrine)
• Tafenoquine (tafenoquine)
• dihydroartemisinin + piperaquine tetraphosphate (dihydroartemisinin + piperaquine tetraphosphate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria, Vivax | Phase 1 | Status: COMPLETED